MedTrace Logo

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

NCT02910284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2017-10-20

No results posted yet for this study

Summary

This study is a follow-up study from Study GEN-003-002 to evaluate long-term efficacy and immunogenicity of GEN-003 in subjects with genital HSV-2 infection.

Conditions

  • Genital Herpes Simplex Type 2

Interventions

BIOLOGICAL

Observational

Sponsors & Collaborators

  • Genocea Biosciences, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-16
Primary Completion
2017-07-14
Completion
2017-07-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02910284 on ClinicalTrials.gov